To characterize the pathway of ceftriaxone penetration into intervertebral discs, rat-tail discs were collected and immersed in a ceftriaxone solution for an in vitro study. For this in vivo experiment, plasma and tail discs were collected 30 min after ceftriaxone administration (463.2 mg/kg, equal to 500 mg/kg disodium salt, iv). The ceftriaxone levels in the plasma and discs were determined with HPLC by a reversed-phase C18 column and a mobile phase of methanol and a 10 mM K2HPO4 solution (pH 6.7) (21:79, v/v). The results indicate that ceftriaxone was undetectable by the in vitro model. The concentrations of ceftriaxone in plasma and in intervertebral discs were 147.4 ± 21.2 and 4.0 ± 1.7 μg/mL (as disodium salt), respectively. Our results suggest that a sufficient blood supply is required for the passive diffusion of ceftriaxone into intervertebral discs. The concentration ratio of ceftriaxone in intervertebral disc-to-plasma was about 2.7% at 30 min after ceftriaxone disodium administration (500 mg/kg, iv). 
Introduction
Ceftriaxone is a third-generation cephalosporin (2-aminothiazolyl methoxyimino cephalosporin) that can inhibit most gram-positive and gram-negative bacteria.
1,2 Figure 1 shows its chemical structure. Since it has a high percentage of protein binding, the serum half-life of ceftriaxone is comparatively long. 1 In in vitro studies, the minimum inhibitory concentration (MIC) of ceftriaxone against bacteria is less than 2 μg/mL.
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After a single intravenous administration, the distribution of ceftriaxone in domestic cats and camels is fast: for these animals, the half-lives of the distribution are 0.14 and 0.24 h, and the volumes of the distribution in the steady state are 0.57 and 0.32 L/kg, respectively.
Therefore, ceftriaxone could be distributed widely in animal body fluids and tissues. [1] [2] [3] [4] There is a high prevalence of postoperative infection in the intervertebral disc space, and the orthopaedist will usually use antibiotics to prevent disc infections. Prophylaxis is a way to decrease the incidence of postoperative discitis, which is an infection in intervertebral disc space. For this, a large bolus of antibiotics is administrated before an operation to maintain the drug concentration to be higher than the minimum inhibitory concentration for a sufficient amount of time. [5] [6] [7] Ceftriaxone is commonly used for treating of bone and joint infections, and its effectiveness has been demonstrated by a case report showing that an antibiotic treatment is often effective at relieving meningoradiculitis pain. After the intramuscular administration of 2 g/day ceftriaxone for three weeks, the pain was resolved. 8 In previous studies on patients with anterior spinal surgery or surgery to remove an intervertebral disc, antibiotic concentrations in the plasma and disc tissues were determined. 6, 7 However, the antibiotic concentrations in the discs, themselves, are still controversial. In this study, we hypothesized that ceftriaxone could penetrate the disc space through passive diffusion. The passive diffusion is governed by Fick's law following the concentration gradient. We therefore developed in vitro and in vivo models to investigate the distribution of ceftriaxone into the intervertebral disc.
Experimental

Chemicals and reagents
Ceftriaxone disodium salt and heparin sodium were purchased from Sigma-Aldrich (St. Louis, MO). Acetonitrile and methanol were both of HPLC grade from Merck KGaA (Darmstadt, Germany). Pure water for all preparations was prepared by a Milli-Q system (Millipore, Milford, MA). Other chemicals, such as sodium chloride, triethylamine (TEA, purity 99%), and dipotassium hydrogen phosphate (K2HPO4), were all purchased from Merck KGaA (Germany).
In vitro model for disc penetration
After anesthetization, the rat's tail was cut and the intervertebral discs were separated (shown in Fig. 2 ). The discs were put into 50 μg/mL of a ceftriaxone disodium salt solution. The discs were collected at 30, 60, 120, 180, and 240 min after immersion. Normal saline was used to wash out any residual solution contamination on the surface of the disc, and then the disc samples were mixed with 3 volumes of methanol for homogenization. The homogenized samples were put in an ice bath, and following centrifugation (9300g, 10 min, 4 C) (Centrifuge 5415R, Eppendorf, Germany) the supernatants were stored at -20 C until analysis.
In vivo model for disc penetration
Animal experimental protocols were reviewed and approved by the Institutional Animal Experimentation Committee of the National Yang-Ming University. Male Sprague-Dawley rats (weighing 230 to 330 g) from the Laboratory Animals Center of National Yang-Ming University were used in these studies. During the experiment, the animals were housed in standard cages in a temperature controlled room with a regular light/dark cycle. Free access to food (Laboratory rodent diet 5001, PMI Feeds, Richmond, IN) and water was supplied at all times.
Six male Sprague-Dawley rats were anesthetized with a mixture solution of urethane (1 g/mL) and α-chloralose (0.1 g/mL) at a dose of 1 mL/kg through intraperitoneal administration. The body temperature of the rat was maintained by a heating pad. Surgical sites were shaved and cleaned with a 70% ethanol solution. To select a suitable dose for ceftriaxone disodium salt administration, dosage ranges of 100 and 500 mg/kg were applied in the pilot study. However, the intervertebral disc concentration was undetectable at a lower dose (100 mg/kg, iv). Therefore, the femoral vein and the jugular vein were cannulated for a higher dose of ceftriaxone (500 mg/kg, iv) administration, and for sampling, respectively. Blood samples were collected from the jugular vein with heparinized syringes at 30 min after dosing. Following centrifugation (3300g, 10 min, 4 C), the plasma was stored at -20 C until analysis. Rat tails were also collected at the same time point as the blood samples, and then the disc samples were separated from the rat tails. A simple protein precipitation was used to remove protein in the discs. Disc samples were rinsed by normal saline, and then 3 volumes of methanol were added for homogenization in an ice bath. After centrifugation (9300g, 10 min, 4 C), the supernatants were stored at -20 C until analysis.
Sample preparation
Plasma samples were precipitated with 2 volumes of acetonitrile for protein precipitation to measure the proteinbound and unbound form. The plasma samples were centrifuged at 9300g for 10 min at 4 C. Finally, the supernatant was collected and analyzed with HPLC.
Analysis of ceftriaxone in rat plasma and intervertebral disc
The HPLC instruments were composed of two LC20AD pumps, a DGU-20A3 on-line degasser, a SIL-20AC autosampler, and a SPD-M20A diode array detector (Shimadzu, Kyoto, Japan). A mobile phase consisting of methanol and 10 mM K2HPO4 buffer at pH 6.7 (21:79, v/v) was pumped through a reversed-phase analytical column (Inertsil ® ODS-3, 250 × 4.6 mm, 5 μm, Merck KGaA, Germany) at room temperature. The flow rate was 1.1 mL/min, and the UV detection wavelength was set at 270 nm. The mobile phase to determine the ceftriaxone level in disc samples was modified from the mobile phase in plasma samples. The phosphate buffer in the analysis condition of ceftriaxone in rat intervertebral disc samples contained 0.1% TEA, and the final pH value of 6.7 was kept the same. The injection volume was 20 μL.
Method validation
Calibration standards were prepared by adding different concentrations of ceftriaxone disodium salt standard solutions (20 μL) into the supernatants of blank pooled plasma after protein precipitation (80 μL). The external standard method was used to plot calibration curves for plasma samples and homogenized intervertebral disc samples.
The intra-day variability was determined by quantifying three replicates at concentrations of 1, 5, and 50 μg/mL (as disodium salt) on the same day, while the inter-day variability was determined on three consecutive days. The calibration curves for the plasma samples, ranging from 0.5 to 50 μg/mL (as disodium salt), were constructed using the same procedure. The intra-/inter-day variability and the calibration curves for the disc samples, ranging from 0.5 to 50 μg/mL (as disodium salt), were constructed using the same procedure as for the plasma samples.
All calibration curves require a correlation value of at least 0.995. To confirm the precision and the accuracy of the analytical method, the intra-and inter-day variabilities were measured with three replicates at three different concentrations, and were operated on the same day and three successive days, respectively. The accuracy was calculated from the nominal concentration (Cnom) and the mean value of observed concentrations (Cobs), as follows: accuracy (%) = [(Cobs -Cnom)/Cnom] × 100. The precision coefficient of variation (CV) was calculated from the standard deviation and the observed concentrations as follows: precision (%) = standard deviation (SD)/Cobs × 100. 
Results and Discussion
Our previous study reported that a biexponential decay model is most appropriate for unbound ceftriaxone in rat blood. 9 In the present work, we further discuss the disc distribution of ceftriaxone. The method selectivity for the separation of ceftriaxone from the endogenous interferences was estimated by analyzing the blank pooled plasma and the intervertebral disc homogenate. In order to improve the separation, 0.1% TEA, which is an ion-pairing agent, was added to the phosphate buffer in the mobile phase. [10] [11] [12] [13] Chromatograms of ceftriaxone in rat intervertebral discs are shown in Fig. 3 . There were no interferences near the retention time of ceftriaxone. The HPLC method in this study was acceptable for the analysis of ceftriaxone. The ceftriaxone in the disc samples had retention times of 7.1 min in isocratic separation with an optimal mobile phase containing methanol and phosphate buffer (21:79, v/v, pH 6.7).
An ion-pairing agent added in the mobile phase was used to prolong the retention of ceftriaxone in the column, and hexadecyltrimethylammonium bromide and cetyltrimethylammonium bromide had been used in previous studies. [9] [10] [11] Triethylamine (TEA) was used here as an organic modifier that acts on residual silanols on the stationary phase. A silica surface possesses a number of attractive properties, but also some drawbacks. One disadvantage is that unreacted or residual silanols interact with basic compounds, and can induce peak tailing, which means a loss in the chromatographic performance. This problem can be solved by modifying the mobile phase or the stationary phase. Different solutions have been proposed, including the suppression of silanol ionization by employing a mobile phase with a low pH and adding a competitive agent in the mobile phase.
Some competitive agents, such as alkylammonium or TEA, can block the silanols, resulting in reduced peak tailing. This study found that the use of TEA could provide a better separation of ceftriaxone in the disc samples.
There is a linear relationship between the peak areas and the ceftriaxone disodium salt concentrations, ranging from 0.5 to 50 μg/mL in plasma and disc homogenates. All of calibration curves were verified by the coefficient of determination (r 2 ) obtained for the regression line (at least 0.995). In this analytical method, the limit of quantitation (LOQ) was 0.5 μg/mL and the limit of detection (LOD) was 0.05 μg/mL. The method precision and the accuracy of ceftriaxone disodium salt in plasma and intervertebral disc samples are given in Tables 1 and  2 , respectively. For plasma analysis, the accuracy ranged from -12.0 to 0.0%, and the precision ranged from 1.1 to 6.4%. For intervertebral disc analysis, the accuracy ranged from -2.0 to 10.0%, and the precision ranged from 2.7 to 12.9%. The recoveries of sample preparations in plasma and intervertebral disc were 83.8 ± 0.1 and 99.5 ± 10.9%, respectively. If the values for the precision and accuracy are less than 15% or less than 20% for the LOQ, which indicates that the method is both easily repeatable and sound.
Clinically, the maximum adult dosage of ceftriaxone is 4 g per day and the apparent plasma level was calculated to be 870 μg/mL. In this in vitro study, the concentration of a ceftriaxone solution was 50 μg/mL (as disodium salt), which is within the usual dosage range and higher than the minimum inhibitory concentration of ceftriaxone (2 μg/mL).
1-3 Therefore, this ceftriaxone concentration is reliable and effective against susceptible bacteria. The in vitro penetration model results showed that the ceftriaxone level in disc homogenates was undetectable. However, in an in vivo experiment for the distribution, the concentrations of ceftriaxone disodium salt in Fig. 3 HPLC/UV chromatograms in rat intervertebral disc samples. Chromatograms of (A) blank rat intervertebral disc, (B) blank rat intervertebral disc containing 5 μg/mL of ceftriaxone disodium salt, (C) rat intervertebral disc at 30 min after ceftriaxone disodium salt administration (500 mg/kg, iv). 1, Ceftriaxone. All the concentrations were shown as disodium salt. plasma and intervertebral discs were 147.4 ± 21.2 and 4.0 ± 1.7 μg/mL, respectively. The ceftriaxone concentrations presented in the plasma and the discs are supposed to prevent infection. According to a previous study, the minimum inhibitory concentration (MIC) of ceftriaxone is usually less than 2 μg/mL. [1] [2] [3] Here, the ceftriaxone disodium salt level in discs (4.0 ± 1.7 μg/mL) was higher than MIC, and within the therapeutic level. Because ceftriaxone could penetrate into the intervertebral disc, and the level of ceftriaxone reached MIC, postoperative discitis could be prevented and the preoperative prophylaxis is meaningful.
The concentration ratio of disc-to-plasma ceftriaxone is about 2.7% (4.0/147.4) from our present results. A previous report indicated that the ratio of the disc-to-serum concentration of ceftriaxone was 1:191 (0.5%) and 1:37 (2.7%) at less than 0.5 h and 0.5 -1 h after an intravenous bolus of 12.5 -16.7 mg/kg of ceftriaxone in patients weighting from 60 to 80 kg, respectively. 7 In our study, the disc-to-plasma ratio at 30 min after the intravenous administration of 500 mg/kg of ceftriaxone disodium salt was 2.7%, which is consistent with the previous report, despite a difference in the species of the experimental animal. 7 The main difference between the in vitro and the in vivo model might have resulted from the blood supply. The disc is avascular, and the transportation of necessary nutrients and metabolic products, such as oxygen and lactic acid, is provided by passive diffusion. 14 The pathways of passive diffusion into the disc are from the cartilage endplate and the annulus of the disc. It has also been reported that the endplate is the main pathway for solute to pass into the nucleus pulposus of an intervertebral disc, and the degree of diffusion depends on a solute's molecular weight, as has been proven by magnetic resonance images (MRI). 15, 16 Consequently, in addition to evidence from previous studies, we find that blood vessels near the disc play an important role in the diffusive transportation of solutes into the intervertebral discs.
Conclusion
In summary, a reversed-phased HPLC method to determine the distribution of ceftriaxone into intervertebral discs has been developed. The results suggest that the penetration of ceftriaxone into intervertebral discs is dependent on the presence of adjacent blood vessels, and a large dose of antibiotics should be necessary in preoperative prophylaxis.
